Navigation Links
Dr. DeLuca of Kessler Foundation speaks at Consortium of MS Centers meeting in Chicago
Date:4/10/2013

West Orange, NJ. April 10, 2013. John DeLuca, PhD, VP of Research & Training at Kessler Foundation, will speak at the Embassy Suites Chicago Downtown-Lakefront in Chicago, Illinois, on April 26, 2013. This one-day CME-accredited program, "Assessing and Managing Neuropsychiatric Problems in Multiple Sclerosis (MS): From MRI to Treatment" is chaired by Ralph Benedict, PhD, and hosted by the Consortium of MS Centers (CMSC). Organized in 1986 under the direction of neurologists interested in the clinical care of MS, CMSC has grown to become a multi-disciplinary organization providing a team approach to MS care and a network for all health care professionals and others specializing in the care of persons with MS.

The educational needs of healthcare professionals working with patients with MS include knowledge of cognitive impairment, which may be mild, moderate, or severe. Dr. DeLuca, an expert in cognitive rehabilitation research, will address "Behavioral Approaches to Cognitive Rehabilitation in Multiple Sclerosis." The program faculty includes Fred Foley, PhD, Robert Zivadinov, MD, PhD, Anthony Feinstein, MD, PhD, and Sarah Morrow, MD, FRCPC, MS.

Registration deadline is April 17.

To register: http://www.mscare.org/events/event_details.asp?id=293444&group= For more information, contact education@mscare.org

About John DeLuca

Dr. DeLuca is VP of Research & Training at Kessler Foundation, which conducts cognitive and physical research in brain injury (TBI), multiple sclerosis, spinal cord injury, and stroke. He specializes in the study of disorders of memory and information processing in TBI and MS and has published more than 200 articles, books, and chapters in these areas. His collaborative work in cognitive rehabilitation extends to Italy, Spain, Portugal, and China. He has obtained more than $26 million in grant funding and is the editor/co-editor of five recent books, including the Encyclopedia of Clinical Neuropsychology, the first encyclopedia of its kind. Dr. DeLuca often presents at national and international conferences and contributes to continuing education for professionals and consumers. He is a professor in the Departments of Physical Medicine & Rehabilitation and Neurology & Neurosciences at University of Medicine and Dentistry of New Jersey-New Jersey Medical School, and a licensed psychologist in the states of New Jersey and New York.

Recent articles:

Chiaravalloti ND, Wylie G, Leavitt V, Deluca J (2012) Increased cerebral activation after behavioral treatment for memory deficits in MS. Journal of Neurology. DOI: 10.1007/s00415-011-6353-x.

Sumowski, J.F., Wylie, G.R., Leavitt, V.M., Chiaravalloti N.D., DeLuca J. (2013). Default network activity is a sensitive and specific biomarker of memory in MS. Multiple Sclerosis Journal, 19, 199-208.

DeLuca, J. & Nocentini, U. (2011). Neuropsychological, medical and rehabilitative management of persons with multiple sclerosis. NeuroRehabilitation, 29, 197-219.


'/>"/>

Contact: Carolann Murphy
CMurphy@kesslerfoundation.org
973-324-8382
Kessler Foundation
Source:Eurekalert

Related medicine news :

1. DeLuca of Kessler Foundation receives research award from American Psychological Association
2. Dr. Deluca of Kessler Foundation receives medical excellence award for MS research
3. John DeLuca, Ph.D., of Kessler Foundation delivers keynote at IPMSC meeting in Milan
4. Kessler Foundation names Dr. John Whyte recipient of Foundations 2nd Annual DeLisa Award
5. Kessler Foundation scientist awarded $554,000 for multiple sclerosis employment research
6. Kessler Foundation researchers present at first International Congress on Cognition in MS
7. Kessler Foundation scientists present cognitive research findings at MS dual symposium
8. Kessler Foundations A.M. Barrett appointed to National Quality Forum Steering Committee
9. Kessler Foundation and Heldrich Center issue brief on hiring workers with disabilities
10. Kessler Foundation presents Brain Injury: From Research to Rebuilding Lives on Sept. 27-28
11. Dr. Chiaravalloti of Kessler Foundation comments on trends in rehabilitation research in MS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... ... ... The California Dental Association Foundation’s two-day volunteer dental clinic, CDA Cares ... April 22-23 event at the San Mateo Event Center. , In addition to ... Cares educates the public and policymakers about the importance of good oral health and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: